News
Promising results for Lead Biologics’ first-in-class checkpoint inhibitor published in Nature Cancer Lead Biologics takes a major step towards a new cancer treatment. A new study shows that the company’s drug candidate effectively inhibits a previously unknown immune escape mechanism and eliminates acute myeloid leukemia cells in advanced experimental models.– This confirms the great interest in
https://www.createhealth.lth.se/news-0 - 2025-10-29
